Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1594495

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1594495

Niacinamide Market by Form (Granular, Liquid, Powder), Production (Natural, Synthetic), Grade, Application - Global Forecast 2025-2030

PUBLISHED:
PAGES: 197 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Niacinamide Market was valued at USD 715.77 million in 2023, expected to reach USD 745.60 million in 2024, and is projected to grow at a CAGR of 4.65%, to USD 984.11 million by 2030.

Niacinamide, a form of vitamin B3, is a multifaceted ingredient widely recognized for its skincare benefits, adding significant value to the cosmetics and personal care industries. Its necessity arises from its anti-inflammatory, anti-aging, and brightening properties, appealing to consumers seeking multifunctional skincare solutions. Niacinamide finds applications in creams, serums, and lotions targeting acne, hyperpigmentation, and skin hydration. The end-use scope extends beyond skincare, encompassing dietary supplements and pharmaceutical products due to its beneficial impacts on the nervous and digestive systems.

KEY MARKET STATISTICS
Base Year [2023] USD 715.77 million
Estimated Year [2024] USD 745.60 million
Forecast Year [2030] USD 984.11 million
CAGR (%) 4.65%

Market growth is primarily driven by increasing consumer awareness of skincare and wellness, escalating demand for natural and versatile ingredients, and the rising prevalence of skin disorders. The burgeoning beauty and personal care industry, with a strong inclination towards organic and sustainable products, catalyzes the market expansion. Furthermore, the integration of niacinamide in diverse product lines fosters multiple entry points and user segments, from premium brands to mass-market offerings.

Despite its promising outlook, market growth faces challenges, including stringent regulations surrounding cosmetic formulations and potential skin sensitivity issues among users. Competitive pressures from alternative ingredients, such as hyaluronic acid and vitamin C, also pose limitations.

To capitalize on market opportunities, companies should focus on innovative formulations that combine niacinamide with complementary ingredients, ensuring optimal product efficacy and consumer satisfaction. Investing in research that explores its broader applications in hair and nail care could unlock additional market spaces. Emphasizing transparency and sustainability in product sourcing and production processes can enhance brand trust and appeal, especially amid increasing consumer environmental consciousness. The market is dynamic and highly competitive, with innovation predominantly reflecting advancements in product delivery methods and enhanced formulations. By staying attuned to evolving consumer preferences and leveraging technological advancements in skincare efficacy testing, businesses can carve out a unique position in this vibrant market space.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Niacinamide Market

The Niacinamide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
    • Increasing demand for skin care products containing niacinamide
    • Growing use of niacinamide for animal feed fortification
  • Market Restraints
    • Limited availability and volatility of the prices of ingredients
  • Market Opportunities
    • Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
    • Growing preference for Over-the-counter (OTC) cosmeceuticals
  • Market Challenges
    • Adverse side effects and allergic reactions associated with the long-term use of niacinamide

Porter's Five Forces: A Strategic Tool for Navigating the Niacinamide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Niacinamide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Niacinamide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Niacinamide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Niacinamide Market

A detailed market share analysis in the Niacinamide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Niacinamide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Niacinamide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Niacinamide Market

A strategic analysis of the Niacinamide Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Niacinamide Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc., Bio-Tech Pharmacal, Inc., Evonik Industries AG, Fagron Inc., Foodchem International Corporation, Gemini Pharmaceuticals, Glanbia PLC, Koninklijke DSM N.V., Lasons India Pvt Ltd., Lonza Group AG, Merck KGaA, NutraScience Labs, Spectrum Chemical Mfg. Corporation, Vertellus LLC, Western Drugs Ltd., and Yuki Gosei Kogyo Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Niacinamide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Granular, Liquid, and Powder.
  • Based on Production, market is studied across Natural and Synthetic.
  • Based on Grade, market is studied across Feed Grade and Pharmaceutical Grade.
  • Based on Application, market is studied across Animal Nutrition, Cosmeceuticals, Human Nutrition, and Pharmaceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-9E01E2DC4AC3

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
      • 5.1.1.2. Increasing demand for skin care products containing niacinamide
      • 5.1.1.3. Growing use of niacinamide for animal feed fortification
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and volatility of the prices of ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
      • 5.1.3.2. Growing preference for Over-the-counter (OTC) cosmeceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse side effects and allergic reactions associated with the long-term use of niacinamide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Niacinamide Market, by Form

  • 6.1. Introduction
  • 6.2. Granular
  • 6.3. Liquid
  • 6.4. Powder

7. Niacinamide Market, by Production

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Niacinamide Market, by Grade

  • 8.1. Introduction
  • 8.2. Feed Grade
  • 8.3. Pharmaceutical Grade

9. Niacinamide Market, by Application

  • 9.1. Introduction
  • 9.2. Animal Nutrition
  • 9.3. Cosmeceuticals
  • 9.4. Human Nutrition
  • 9.5. Pharmaceuticals

10. Americas Niacinamide Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Niacinamide Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Niacinamide Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AIE Pharmaceuticals, Inc.
  • 2. Bio-Tech Pharmacal, Inc.
  • 3. Evonik Industries AG
  • 4. Fagron Inc.
  • 5. Foodchem International Corporation
  • 6. Gemini Pharmaceuticals
  • 7. Glanbia PLC
  • 8. Koninklijke DSM N.V.
  • 9. Lasons India Pvt Ltd.
  • 10. Lonza Group AG
  • 11. Merck KGaA
  • 12. NutraScience Labs
  • 13. Spectrum Chemical Mfg. Corporation
  • 14. Vertellus LLC
  • 15. Western Drugs Ltd.
  • 16. Yuki Gosei Kogyo Co., Ltd.
Product Code: MRR-9E01E2DC4AC3

LIST OF FIGURES

  • FIGURE 1. NIACINAMIDE MARKET RESEARCH PROCESS
  • FIGURE 2. NIACINAMIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NIACINAMIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY GRANULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY HUMAN NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!